ENTRY       C07073                      Compound
NAME        Lidocaine
FORMULA     C14H22N2O
EXACT_MASS  234.1732
MOL_WEIGHT  234.3373
REMARK      Same as: D00358
REACTION    R08293 R08294 R08300
PATHWAY     map00982  Drug metabolism - cytochrome P450
ENZYME      1.14.13.-       1.14.14.1       3.1.1.1
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C01 CARDIAC THERAPY
               C01B ANTIARRHYTHMICS, CLASS I AND III
                C01BB Antiarrhythmics, class Ib
                 C01BB01 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
              C05 VASOPROTECTIVES
               C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
                C05AD Local anesthetics
                 C05AD01 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
             D DERMATOLOGICALS
              D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
               D04A ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.
                D04AB Anesthetics for topical use
                 D04AB01 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01B ANESTHETICS, LOCAL
                N01BB Amides
                 N01BB02 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
             R RESPIRATORY SYSTEM
              R02 THROAT PREPARATIONS
               R02A THROAT PREPARATIONS
                R02AD Anesthetics, local
                 R02AD02 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01H LOCAL ANESTHETICS
                S01HA Local anesthetics
                 S01HA07 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
              S02 OTOLOGICALS
               S02D OTHER OTOLOGICALS
                S02DA Analgesics and anesthetics
                 S02DA01 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
            USP drug classification [BR:br08302]
             Anesthetics
              Local Anesthetics
               Lidocaine
                D00358  Lidocaine (JP16/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              12  Agents affecting peripheral nervous system
               121  Local anesthetics
                1214  Xylidines
                 D00358  Lidocaine (JP16/USP/INN)
            Classification of Japanese OTC drugs [BR:br08313]
             Agents for  urogenital organs and anus
              30 Hemorrhoid drugs for external use
               D00358  Lidocaine (JP16/USP/INN)
              -- Suppository for hemorrhoid
               D00358  Lidocaine (JP16/USP/INN)
              -- Hemorrhoid oinments
               D00358  Lidocaine (JP16/USP/INN)
             Agents for integumentary system
              57 Analgesic, antipruritic, astringent, and anti-inflammatory remedies (incl. gel patches)
               D00358  Lidocaine (JP16/USP/INN)
              -- Eczematous and dermatitis remedies
               D00358  Lidocaine (JP16/USP/INN)
              -- Antipruritic and insect sting remedies
               D00358  Lidocaine (JP16/USP/INN)
            Risk category of Japanese OTC drugs [BR:br08312]
             Category 2
              Inorganic and organic chemicals
               Lidocaine
                D00358  Lidocaine (JP16/USP/INN)
            Pharmaceutical additives [BR:br08316]
             Soothing agent
              D00358  [001667] Lidocaine
             Solubilizer
              D00358  [001667] Lidocaine
             Solubilization agent
              D00358  [001667] Lidocaine
             Solvent
              D00358  [001667] Lidocaine
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Voltage-gated cation channels
               Na+ channel, SCN alpha, NaV1.x
                voltage-gated sodium channel (SCN1A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
                voltage-gated sodium channel (SCN2A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
                voltage-gated sodium channel (SCN3A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
                voltage-gated sodium channel (SCN4A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
                voltage-gated sodium channel (SCN5A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
                voltage-gated sodium channel (SCN8A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
                voltage-gated sodium channel (SCN9A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
                voltage-gated sodium channel (SCN10A)
                 Lidocaine
                  D00358  Lidocaine (JP16/USP/INN)
            Cytochrome P450 interactions [BR:br08309]
             Substrates
              CYP1A2
               Lidocaine
                D00358  Lidocaine (JP16/USP/INN)
              CYP2D6
               Lidocaine
                D00358  Lidocaine (JP16/USP/INN)
              CYP3A4
               Lidocaine
                D00358  Lidocaine (JP16/USP/INN)
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00358  Lidocaine
              D00358  Lidocaine injection
DBLINKS     CAS: 137-58-6
            PubChem: 9284
            PDB-CCD: LQZ
            NIKKAJI: J5.631F
ATOM        17
            1   C8y C    23.2602  -19.0646
            2   N1b N    24.4935  -19.7778
            3   C8y C    22.0325  -19.7836
            4   C8y C    23.2602  -17.6441
            5   C5a C    25.7213  -19.0587
            6   C8x C    20.8049  -19.0646
            7   C1a C    22.0384  -21.1983
            8   C8x C    22.0325  -16.9367
            9   C1a C    24.4818  -16.9367
            10  C1b C    26.9488  -19.7778
            11  O5a O    25.7096  -17.6332
            12  C8x C    20.8049  -17.6441
            13  N1c N    28.1823  -19.0587
            14  C1b C    29.4158  -19.7778
            15  C1b C    28.1823  -17.6441
            16  C1a C    30.6317  -19.0587
            17  C1a C    29.4158  -16.9309
BOND        17
            1     1   2 1
            2     1   3 2
            3     1   4 1
            4     2   5 1
            5     3   6 1
            6     3   7 1
            7     4   8 2
            8     4   9 1
            9     5  10 1
            10    5  11 2
            11    6  12 2
            12   10  13 1
            13   13  14 1
            14   13  15 1
            15   14  16 1
            16   15  17 1
            17    8  12 1
///
